Bioequivalence Study Between Temozolomide Oral Suspension (Ped-TMZ) and Temodal® Capsules
Clinical trial NCT04467346 · COMPLETED
Trial details
- NCT number
- NCT04467346
- Sponsor
- Orphelia Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2021-12-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.